Please login to view this media
- Talk
- 21/09/2021
- UK
The Aberdeen Outpatient Dedicated Percutaneous Needle Fasciotomy Clinic for the Treatment of Dupuytren’s Disease. A Valuable Resource in the Re-establishment of Orthopaedic Service following the Coronavirus Pandemic
Description
The VTT transcription captures a detailed discussion led by Yasmeen Khan regarding Dupuytren disease and the implementation of a percutaneous needle fasciotomy clinic established by the Aberdeen team, operational for over a decade. The presentation begins with acknowledgments and a brief overview of the prevalence of Dupuytren disease, particularly in Aberdeen compared to London, highlighting the necessity to adapt clinical practices for managing patient care amid increasing elective surgery waits exacerbated by the COVID-19 pandemic.
Key points include:
- An explanation of percutaneous needle fasciotomy as an effective outpatient procedure, which allows for the division of cords without tissue removal, followed by a six-month splinting protocol.
- A retrospective review of 100 patients was conducted to assess outcomes and demographics, indicating that most patients were male and presented with grades 1 and 2 Dupuytren disease.
- The procedure's significant outcomes, including low complication rates, successful outcomes with repeatability, and the ability for patients to return to their activities more quickly compared to traditional surgical methods.
- The prospect of using percutaneous needle fasciotomy more widely in England as an alternative given the discontinuation of collagenase treatments.
Additionally, the transcript includes a question-and-answer segment, where audience members inquire about the structure of the clinic, patient assessment processes, and the feasibility of incorporating virtual consultations into the treatment model. Yasmeen emphasizes the importance of in-person assessments for Dupuytren disease to ensure accurate treatment planning, reflecting an adaptive healthcare approach in response to patient needs and operational constraints.